Procter & Gamble Co. v. QuantifiCare Inc.

Plaintiffs Procter & Gamble Co. ("P&G") and Canfield Scientific, Inc. ("Canfield") (collectively, "Plaintiffs") filed a patent infringement suit against Defendant QuantifiCare Inc. ("QuantifiCare"). Plaintiffs allege that QuantifiCare infringes claims of U.S. Patent No. 6,571,003 ("the '003 Patent"). Before the Court is QuantifiCare's Motion to Dismiss, which contends that the asserted claims of the '003 Patent fail to recite patent-eligible subject matter under 35 U.S.C. § 101 . ECF No. 35 ("Mot."). Having considered the submissions of the parties, the relevant law, and the record in this case, the Court GRANTS in part and DENIES in part QuantifiCare's Motion to Dismiss.

I. BACKGROUND

A. Factual Background

1. The Parties

Plaintiff P&G is an Ohio corporation with its primary place of business in Cincinnati, Ohio. ECF No. 33 ("First Amended Complaint" or "FAC") ¶ 1. P&G is the assignee of the '003 Patent. Id. Plaintiff Canfield is a New Jersey corporation with its primary place of business in Parsippany, New Jersey. Id. ¶ 2 . Canfield is the sole licensee of the '003 Patent. Id. Defendant QuantifiCare is a California corporation with its primary place of business in San Mateo,…